Literature DB >> 6142458

A diet enriched in vitamin A acetate or in vivo administration of interleukin-2 can counteract a tolerogenic stimulus.

M Malkovský, P Medawar, R Hunt, L Palmer, C Doré.   

Abstract

A conventional diet enriched in retinyl acetate (vitamin A acetate; VAA) or in vivo administration of exogenous interleukin-2 (IL-2) can effectively annul the otherwise tolerogenic stimulus represented by (CBA X C57BL/10ScSn) F1 cells injected intraperitoneally into newborn CBA mice. On the basis of these data and results of others, we postulate that an antigenic stimulus associated with a relative lack of IL-2 (or generally the lack of a 'secondary stimulus') can be tolerogenic rather than immunogenic. However, the tolerogenicity of the antigenic stimulus can be substantially reduced or even converted to sensitization (R. P. Cleveland & H. N. Claman, J. Immun. 124, 474-480, 1980), when the antigenic signal is appropriately associated with a concomitant or additional stimulus possibly mediated through IL-2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142458     DOI: 10.1098/rspb.1984.0012

Source DB:  PubMed          Journal:  Proc R Soc Lond B Biol Sci        ISSN: 0950-1193


  14 in total

Review 1.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

2.  Retinoid- and carotenoid-enriched diets influence the ontogenesis of the immune system in mice.

Authors:  Ada L Garcia; Ralph Rühl; Udo Herz; Corinna Koebnick; Florian J Schweigert; Margitta Worm
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

3.  Regulation of accessory cell function by retinoids in murine immune responses.

Authors:  D R Katz; M Drzymala; J A Turton; R M Hicks; R Hunt; L Palmer; M Malkovský
Journal:  Br J Exp Pathol       Date:  1987-06

Review 4.  Retinol (vitamin A) supplements in the elderly.

Authors:  B J Ward
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

5.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

6.  Autologous lymphoid cells exposed to recombinant interleukin-2 in vitro in the absence of antigen can induce the rejection of long-term tolerated skin allografts.

Authors:  B Loveland; R Hunt; M Malkovský
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

7.  Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer.

Authors:  M Scudeletti; G Filaci; M A Imro; G Motta; M Di Gaetano; I Pierri; S Tongiani; F Indiveri; F Puppo
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

8.  In vivo activity of interleukin-2: conversion of a stimulus causing unresponsiveness to a stimulus causing contact hypersensitivity by the injection of interleukin-2.

Authors:  V Colizzi; M Malkovsky; G Lang; G L Asherson
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

9.  Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes.

Authors:  M Spitz; A Gearing; M Callus; L Spitz; R Thorpe
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

10.  Generation of lymphokine-activated killer cells does not require DNA synthesis.

Authors:  M Malkovský; M Jíra; J Madar; V Malkovska; B Loveland; G L Asherson
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.